Trial Profile
Radiotherapy + oxaliplatin versus radiotherapy alone in patients with locoregionally advanced nasopharyngeal cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Sep 2013
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary)
- Indications Nasopharyngeal cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2010 New trial record.